{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:04:11Z","timestamp":1770746651096,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Veterinary Cardiology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jvc.2017.06.001","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T15:16:01Z","timestamp":1500477361000},"page":"325-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of dogs with compensated myxomatous mitral valve disease with spironolactone\u2014a pilot study"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1890-6161","authenticated-orcid":false,"given":"M.J.","family":"Hezzell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Boswood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"L\u00f3pez-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"L\u00f6tter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvc.2017.06.001_bib1","series-title":"Textbook of Canine and Feline Cardiology","first-page":"457","article-title":"Prevalence of cardiovascular disorders","author":"Buchanan","year":"1999"},{"key":"10.1016\/j.jvc.2017.06.001_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1751-0147-46-121","article-title":"Mortality in over 350,000 insured Swedish dogs from 1995\u20132000: II. Breed-specific age and survival patterns and relative risk for causes of death","volume":"46","author":"Egenvall","year":"2005","journal-title":"Acta Vet Scand"},{"key":"10.1016\/j.jvc.2017.06.001_bib3","series-title":"Small Animal Cardiovascular Medicine","first-page":"297","article-title":"Myxomatous atrioventricular valvular degeneration","author":"Kittleson","year":"1998"},{"key":"10.1016\/j.jvc.2017.06.001_bib4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1939-1676.2009.0392.x","article-title":"Guidelines for the diagnosis and treatment of canine chronic valvular heart disease","volume":"23","author":"Atkins","year":"2009","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.06.001_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1939-1676.2007.0008.x","article-title":"Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease","volume":"22","author":"Borgarelli","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.06.001_bib6","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1939-1676.2008.0150.x","article-title":"Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study","volume":"22","author":"Haggstrom","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.06.001_bib7","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/jvim.14586","article-title":"Effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: the EPIC study-a randomized clinical trial","volume":"30","author":"Boswood","year":"2016","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.06.001_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1748-5827.2009.00889.x","article-title":"N-terminal pro B-type natriuretic peptide and left ventricular diameter independently predict mortality in dogs with mitral valve disease","volume":"51","author":"Moonarmart","year":"2010","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.jvc.2017.06.001_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1939-1676.2012.00894.x","article-title":"The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease","volume":"26","author":"Hezzell","year":"2012","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.06.001_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1939-1676.2011.00860.x","article-title":"Survival characteristics and prognostic variables of dogs with preclinical chronic degenerative mitral valve disease attributable to myxomatous degeneration","volume":"26","author":"Borgarelli","year":"2012","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.06.001_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1939-1676.1995.tb01092.x","article-title":"Activation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency","volume":"9","author":"Pedersen","year":"1995","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.06.001_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2004.05.004","article-title":"Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy","volume":"96","author":"Tan","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jvc.2017.06.001_bib13","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2460\/ajvr.73.11.1765","article-title":"Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease","volume":"73","author":"Hezzell","year":"2012","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jvc.2017.06.001_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1939-1676.2009.0467.x","article-title":"Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease","volume":"24","author":"Bernay","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.06.001_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/cpt1974155443","article-title":"Minimization: a new method of assigning patients to treatment and control groups","volume":"15","author":"Taves","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jvc.2017.06.001_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1748-5827.2006.00264.x","article-title":"Measurement of aldosterone in feline, canine and human urine","volume":"48","author":"Syme","year":"2007","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.jvc.2017.06.001_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1760-2734(06)70054-6","article-title":"Validation of an immunoassay for measurement of canine cardiac troponin-I","volume":"6","author":"Oyama","year":"2004","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2017.06.001_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jvim.12472","article-title":"Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay","volume":"29","author":"Fox","year":"2015","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.06.001_bib19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1740-8261.2002.tb01051.x","article-title":"Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in cavalier King Charles spaniels with and without left atrial enlargement","volume":"43","author":"Hansson","year":"2002","journal-title":"Vet Radiol Ultrasound"},{"key":"10.1016\/j.jvc.2017.06.001_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1939-1676.2004.tb02551.x","article-title":"Allometric scaling of M-mode cardiac measurements in normal adult dogs","volume":"18","author":"Cornell","year":"2004","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.06.001_bib21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/AOG.0b013e3181d9d421","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"115","author":"Schulz","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jvc.2017.06.001_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jvc.2012.01.009","article-title":"Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease","volume":"14","author":"Hezzell","year":"2012","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2017.06.001_bib23","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1939-1676.2011.00792.x","article-title":"Radiographic heart size and its rate of increase as tests for onset of congestive heart failure in Cavalier King Charles Spaniels with mitral valve regurgitation","volume":"25","author":"Lord","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.06.001_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jvc.2017.06.001_bib25","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/jvim.12141","article-title":"Safety of spironolactone in dogs with chronic heart failure because of degenerative valvular disease: a population-based, longitudinal study","volume":"27","author":"Lefebvre","year":"2013","journal-title":"J Vet Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.jvc.2017.06.001_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1748-5827.2009.00803.x","article-title":"Can ventricular function be assessed by echocardiography in chronic canine mitral valve disease?","volume":"50","author":"Bonagura","year":"2009","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.jvc.2017.06.001_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2460\/javma.2002.221.381","article-title":"Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus","volume":"221","author":"Schober","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2017.06.001_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jvim.13801","article-title":"Cardiac troponins in dogs and cats","volume":"30","author":"Langhorn","year":"2016","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.06.001_bib29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/1074248410387606","article-title":"Aldosterone antagonists in heart failure","volume":"16","author":"Guglin","year":"2011","journal-title":"J Cardiovasc Pharmacol Ther"}],"container-title":["Journal of Veterinary Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273417300279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273417300279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:02:54Z","timestamp":1535587374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1760273417300279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1760273417300279"],"URL":"https:\/\/doi.org\/10.1016\/j.jvc.2017.06.001","relation":{},"ISSN":["1760-2734"],"issn-type":[{"value":"1760-2734","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of dogs with compensated myxomatous mitral valve disease with spironolactone\u2014a pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of Veterinary Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvc.2017.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}